Safety of Antiplatelet Agents: Analysis of ‘Real-World’ Data from the Italian National Pharmacovigilance Network
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-1918
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Safety of Antiplatelet Agents: Analysis of ‘Real-World’ Data from the Italian National Pharmacovigilance Network ; volume:37 ; number:11 ; day:30 ; month:8 ; year:2017 ; pages:1067-1081 ; date:11.2017
Clinical drug investigation ; 37, Heft 11 (30.8.2017), 1067-1081, 11.2017
- Schlagwort
-
Biopharmazie
Pharmakodynamik
Pharmakokinetik
- Urheber
-
Gozzo, Lucia
- Beteiligte Personen und Organisationen
-
Navarria, Andrea
Benfatto, Giuseppe
Longo, Laura
Mansueto, Silvana
Sottosanti, Laura
Pani, Luca
Salomone, Salvatore
Drago, Filippo
SpringerLink (Online service)
- DOI
-
10.1007/s40261-017-0566-4
- URN
-
urn:nbn:de:1111-2017121113628
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:25 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Gozzo, Lucia
- Navarria, Andrea
- Benfatto, Giuseppe
- Longo, Laura
- Mansueto, Silvana
- Sottosanti, Laura
- Pani, Luca
- Salomone, Salvatore
- Drago, Filippo
- SpringerLink (Online service)
Ähnliche Objekte (12)
Antiplatelet agents
Lumbar puncture in patients using anticoagulants and antiplatelet agents
Perioperative Guidelines on Antiplatelet and Anticoagulant Agents: 2022 Update
A real-world disproportionality analysis of Rucaparib: Post-marketing Pharmacovigilance Data
Endoscopy and antiplatelet agents. European Society of Gastrointestinal Endoscopy (ESGE) Guideline
Risk of Gastrointestinal Bleed and Endoscopic Procedures on Antiplatelet and Antithrombotic Agents
Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology
A real-world pharmacovigilance study of FDA adverse event reporting system events for Capmatinib
Adverse event profiles of selpercatinib: a real-world pharmacovigilance analysis based on FAERS database
The risk of bleeding for antiplatelet agents in Haemodialysis patients: a Meta-analysis
Pharmacovigilance in oncology
A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for niraparib
Antiplatelet agents
Lumbar puncture in patients using anticoagulants and antiplatelet agents
Perioperative Guidelines on Antiplatelet and Anticoagulant Agents: 2022 Update
A real-world disproportionality analysis of Rucaparib: Post-marketing Pharmacovigilance Data
Endoscopy and antiplatelet agents. European Society of Gastrointestinal Endoscopy (ESGE) Guideline
Risk of Gastrointestinal Bleed and Endoscopic Procedures on Antiplatelet and Antithrombotic Agents
Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology
A real-world pharmacovigilance study of FDA adverse event reporting system events for Capmatinib
Adverse event profiles of selpercatinib: a real-world pharmacovigilance analysis based on FAERS database
The risk of bleeding for antiplatelet agents in Haemodialysis patients: a Meta-analysis
Pharmacovigilance in oncology
A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for niraparib
Antiplatelet agents
Lumbar puncture in patients using anticoagulants and antiplatelet agents
Perioperative Guidelines on Antiplatelet and Anticoagulant Agents: 2022 Update
A real-world disproportionality analysis of Rucaparib: Post-marketing Pharmacovigilance Data
Endoscopy and antiplatelet agents. European Society of Gastrointestinal Endoscopy (ESGE) Guideline
Risk of Gastrointestinal Bleed and Endoscopic Procedures on Antiplatelet and Antithrombotic Agents
Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology
A real-world pharmacovigilance study of FDA adverse event reporting system events for Capmatinib
Adverse event profiles of selpercatinib: a real-world pharmacovigilance analysis based on FAERS database
The risk of bleeding for antiplatelet agents in Haemodialysis patients: a Meta-analysis
Pharmacovigilance in oncology